Health Care

Indira IVF hits a first in India, inaugurates its 100th infertility treatment centre

~A market leader, Indira IVF is the first single specialty IVF chain to attain the milestone~ 

New Delhi, August 21, 2021: With the inauguration of two new centres at Uttar Pradesh’s Sultanpur and Bathinda in Punjab, Indira IVF, India’s largest infertility speciality clinics chain, has notched a major milestone of establishing 100 centres across India. The organisation came out with the watershed announcement as it completes over a decade of seminally aiding couples with realising their dreams of growing their families. It is the first single-speciality infertility treatment chain in India to have 100 fertility centres under its banner. 

As a purpose-driven pioneering organisation, Indira IVF has always prided itself on accessibility by taking IVF treatment to even the remotest parts of the country. All of this empowers patients in tier 2 and tier 3 cities, in particular, to secure medically proven solutions and also provides for a much-needed respite financially to those needy lot as couples do not have to travel afar for their treatments. By way of this, Indira IVF has cradled more than 85,000 couples helping them conceive since 2011 and, in turn, cementing its position as a staunch market leader and the most trusted single- specialty fertility chain in India. 

Reflecting on the journey, Dr Ajay Murdia – Founder & Chairman, Indira IVF Group said, “We started as a humble diagnostic clinic with sperm bank facilities in 1988 before foraying into IVF treatments a decade ago. Our growth and the number of couples we have been able to help over the years is an indication of the change in attitude towards IVF and infertility in the country. We are pleased to be a part of this journey as more people opt for medical solutions for their health conditions.” 

Speaking on the milestone, Dr Kshitiz Murdia – CEO & Co-Founder of Indira IVF said, “We are delighted to open our 100th centre and lend a helping hand to more couples who dream of parenthood. With this milestone, we aspire to strive to continually impact thousands of lives. As a part of our continued venture, we plan to increase our reach in the Eastern and Southern regions of the country. We are also keen to expand into the international market in Southeast Asia to provide state-of-the-art IVF facilities at affordable prices.” 

Talking about the progress in IVF technology Nitiz Murdia, Director and Co-Founder of Indira IVF said, “The landscape of IVF has changed manifold and we have a number of technologies today that minimise risk factors and ensure better outcomes. New advancements in assisted reproductive technology such as artificial intelligence (AI) are taking place regularly and at Indira IVF, we always keep our doors open to adoption of any such technology which would prove beneficial for couples in their journey of bearing children.” 

Parallel with all the developments, Indira IVF also received a significant minority investment from TA associates, a leading Boston-based global growth private equity firm in 2019.  Following that Indira’s network of IVF centres has further expanded in number to 40.  As a technology-first organization and as boasting of having the country’s largest network of IVF centres, Indira is today a pillar of support for countless couples to navigate through the meandering and often tedious journey of starting a family, in the first place, altogether.

Corporate Comm India (CCI Newswire)

The Pharma Times News Bureau

Recent Posts

Gleneagles Hospital Mumbai Introduces Pediatric Bone Marrow Transplant (BMT) Facility

New Delhi, May 17, 2024: In response to the growing need for specialized pediatric care,…

2 days ago

Ramaiah Memorial Hospital Launches Novel Intra-Operative Radiation Therapy (IORT);

Achieves significant advancement in Cancer Treatment to Enhance Quality of Life  As per the National…

3 days ago

Two Complex Robotic Kidney Transplant Surgeries Successfully Performed at Fortis Hospital Bannerghatta Road

-An 11-year-old boy from Yemen and a 34-year-old man from Bengaluru, both suffered from end-stage…

4 days ago

On International Nurses Day, American Oncology Institute (AOI) launches #TheExtraordinaryCareGiver Campaign as Tribute to Oncology Nurses

Mumbai, 14th May 2024 – As part of its dedication to exceptional patient care, American Oncology…

5 days ago

SOCC Unveils A New Era In Paediatric Care: Second Opinion Online Consultations For Children

Mumbai, May 11, 2024: In a landmark move for Indian healthcare, the introduction of Second…

1 week ago

India’s First Lady Surgeon Trained in Robotic Breast Surgery Performs Karnataka’s 1st Robotic Nipple Sparing Mastectomy

Bengaluru, May 08, 2024: Cancer remains the illness most feared across the globe. But to combat…

2 weeks ago

Notice: ob_end_flush(): failed to send buffer of zlib output compression (0) in /home2/theprkho/public_html/thepharmatimes.in/wp-includes/functions.php on line 5420